Outbreak of infections caused by shigella sonnei with reduced susceptibility to azithromycin in the united states

Antimicrobial Agents and Chemotherapy

Volumn 57, Issue 3, 2013, Pages 1559-1560

  Karlsson, Maria Sjölund ^a   Bowen, Anna ^a   Reporter, Roshan ^b   Folster, Jason P ^a   Grass, Julian E ^a   Howie, Rebecca L ^c   Taylor, Julia ^c   Whichard, Jean M ^a  

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^b LOS ANGELES COUNTY DEPARTMENT OF PUBLIC HEALTH   (United States)

^c Ihrc Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; AZITHROMYCIN; CEFOXITIN; CEFTRIAXONE; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; KANAMYCIN; NALIDIXIC ACID; STREPTOMYCIN; SULFAFURAZOLE; TETRACYCLINE;

ADULT; AGED; ANTIBIOTIC SENSITIVITY; BACTERIUM ISOLATE; CASE REPORT; DISEASE DURATION; DISEASE SEVERITY; FEMALE; HUMAN; LETTER; MALE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; SHIGELLA SONNEI; SHIGELLOSIS;

AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; AZITHROMYCIN; DISEASE OUTBREAKS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; DYSENTERY, BACILLARY; ELECTROPHORESIS, GEL, PULSED-FIELD; FEMALE; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; SHIGELLA SONNEI; UNITED STATES;

EID: 84874059949     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.02360-12     Document Type: Letter

References (10)

1. Scallan E, Hoekstra RM, Angulo FJ, Tauxe RV, Widdowson MA, Roy SL, Jones JL, Griffin PM. 2011. Foodborne illness acquired in the United States-major pathogens. Emerg. Infect. Dis. 17:7-15.
2. Arvelo W, Hinkle CJ, Nguyen TA, Weiser T, Steinmuller N, Khan F, Gladbach S, Parsons M, Jennings D, Zhu BP, Mintz E, Bowen A. 2009. Transmission risk factors and treatment of pediatric shigellosis during a large daycare center-associated outbreak of multidrug resistant Shigella sonnei: implications for the management of shigellosis outbreaks among children. Pediatr. Infect. Dis. J. 28:976 -980.
3. Shiferaw B, Solghan S, Palmer A, Joyce K, Barzilay EJ, Krueger A, Cieslak P. 2012. Antimicrobial susceptibility patterns of Shigella isolates in Foodborne Diseases Active Surveillance Network (FoodNet) sites, 2000-2010. Clin. Infect. Dis. 54(Suppl. 5):S458 -S463.
4. Christopher PRH, David KV, John SM, Sankarapandian V. 2010. Antibiotic therapy for Shigella dysentery. Cochrane Database Syst. Rev. 2010(8):CD006784. doi:10.1002/14651858.CD006784.pub4.
5. Basualdo W, Arbo A. 2003. Randomized comparison of azithromycin versus cefixime for treatment of shigellosis in children. Pediatr. Infect. Dis. J. 22:374 -377.
6. American Academy of Pediatrics. 2012. Shigella infections, p 645-647. In Pickering LK, Baker CJ, Kimberlin DW, Long SS (ed), Red book: 2012 report of the Committee on Infectious Diseases, 29th ed. American Academy of Pediatrics, Elk Grove Village, IL.
7. Guerrant RL, Van Gilder T, Steiner TS, Thielman NM, Slutsker L, Tauxe RV, Hennessy T, Griffin PM, DuPont H, Sack RB, Tarr P, Neill M, Nachamkin I, Reller LB, Osterholm MT, Bennish ML, Pickering LK. 2001. Practice guidelines for the management of infectious diarrhea. Clin. Infect. Dis. 32:331-351.
8. Howie RL, Folster JP, Bowen A, Barzilay EJ, Whichard JM. 2010. Reduced azithromycin susceptibility in Shigella sonnei, United States. Microb. Drug Resist. 16:245-248.
9. Boumghar-Bourtchai L, Mariani-Kurkdjian P, Bingen E, Filliol I, Dhalluin A, Ifrane SA, Weill FX, Leclercq R. 2008. Macrolide-resistant Shigella sonnei. Emerg. Infect. Dis. 14:1297-1299.
10. Carattoli A, Bertini A, Villa L, Falbo V, Hopkins KL, Threlfall EJ. 2005. Identification of plasmids by PCR-based replicon typing. J. Microbiol. Methods 63:219 -228.